Phase 3 ADorable-1 trial results show lebrikizumab-libkz provides skin clearance and itch relief in children with moderate to severe atopic dermatitis.

Robert Sidbury, MD, MPH, professor of pediatrics at Seattle Children's Hospital, discusses treatment approaches for atopic dermatitis of the face in infancy, which he presented at the Revolutionizing ...

Please provide your email address to receive an email when new articles are posted on . Infants with atopic dermatitis at age 1 month had higher expression of genes involved in immune responses. Sebum ...

Organon & Co. (OGN) announced an update on their ongoing clinical study. Organon & Co. has initiated a Phase 3 clinical study titled A Randomized, Double-Blind, Vehicle-Controlled (Period 1) and ...

A randomized clinical trial has found that applying daily full-body emollient on infants beginning before age 9 weeks reduced the risk of atopic dermatitis (AD) by the second birthday. Simpson and ...

Robert Sidbury, MD, MPH, professor of pediatrics at Seattle Children's Hospital, discusses best practices that physicians and parents of infants with atopic dermatitis (AD) can do to help manage flare ...

Recent study findings published in Allergy suggest that twice-daily application of emollients within the first 8 weeks of life significantly reduces the cumulative incidence of atopic dermatitis (AD) ...

JMIR Publications recently published "Effectiveness of Pediatric Teleconsultation to Prevent Skin Conditions in Infants and Reduce Parenting Stress in Mothers: Randomized Controlled Trial" in JMIR ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Infants born during the COVID-19 lockdown in Ireland ...

A rash may be a symptom of contact dermatitis, which occurs when a substance irritates a person’s skin. People can use a range of treatments to manage contact dermatitis. This article explores what ...

58% of participants achieved a 75% improvement in Eczema Area and Severity Index (EASI-75) with ZORYVE cream 0.05% at Week 4 Investigational ZORYVE cream 0.05% was well tolerated and demonstrated a ...

What is contact dermatitis? Contact dermatitis is a reaction that occurs when something touches your skin and triggers a rash. The rash may appear right away or it could take some time to develop.